Prostate Cancer and Prostatic Diseases, Published online: 05 November 2026; doi:10.1038/s41391-026-01176-7 PRAISE-U: from pilot to program—what clinicians need to know from population-based screening for prostate cancer
M. J. Roobol, R. C. N. van den Bergh, S. Collen, A. Chandran, H. Van Poppel. PRAISE-U: from pilot to program—what clinicians need to know from population-based screening for prostate cancer. // Prostate Cancer and Prostatic Diseases. – 2026. – DOI: 10.1038/s41391-026-01176-7. – URL: https://www.nature.com/articles/s41391-026-01176-7
M. J. Roobol, R. C. N. van den Bergh, S. Collen, A. Chandran, & H. Van Poppel (2026). PRAISE-U: from pilot to program—what clinicians need to know from population-based screening for prostate cancer. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-026-01176-7
M. J. Roobol, et al. “PRAISE-U: from pilot to program—what clinicians need to know from population-based screening for prostate cancer.” Prostate Cancer and Prostatic Diseases, 2026. doi:10.1038/s41391-026-01176-7.
@article{Roobol2026,
title = {PRAISE-U: from pilot to program—what clinicians need to know from population-based screening for prostate cancer},
author = {Roobol, M. J. and Bergh, R. C. N. van den and Collen, S. and Chandran, A. and Poppel, H. Van},
journal = {Prostate Cancer and Prostatic Diseases},
year = {2026},
doi = {10.1038/s41391-026-01176-7},
url = {https://www.nature.com/articles/s41391-026-01176-7}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...